Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Jan 15;25(1):26.
doi: 10.1186/s12859-024-05639-3.

Methodology for biomarker discovery with reproducibility in microbiome data using machine learning

Affiliations

Methodology for biomarker discovery with reproducibility in microbiome data using machine learning

David Rojas-Velazquez et al. BMC Bioinformatics. .

Abstract

Background: In recent years, human microbiome studies have received increasing attention as this field is considered a potential source for clinical applications. With the advancements in omics technologies and AI, research focused on the discovery for potential biomarkers in the human microbiome using machine learning tools has produced positive outcomes. Despite the promising results, several issues can still be found in these studies such as datasets with small number of samples, inconsistent results, lack of uniform processing and methodologies, and other additional factors lead to lack of reproducibility in biomedical research. In this work, we propose a methodology that combines the DADA2 pipeline for 16s rRNA sequences processing and the Recursive Ensemble Feature Selection (REFS) in multiple datasets to increase reproducibility and obtain robust and reliable results in biomedical research.

Results: Three experiments were performed analyzing microbiome data from patients/cases in Inflammatory Bowel Disease (IBD), Autism Spectrum Disorder (ASD), and Type 2 Diabetes (T2D). In each experiment, we found a biomarker signature in one dataset and applied to 2 other as further validation. The effectiveness of the proposed methodology was compared with other feature selection methods such as K-Best with F-score and random selection as a base line. The Area Under the Curve (AUC) was employed as a measure of diagnostic accuracy and used as a metric for comparing the results of the proposed methodology with other feature selection methods. Additionally, we use the Matthews Correlation Coefficient (MCC) as a metric to evaluate the performance of the methodology as well as for comparison with other feature selection methods.

Conclusions: We developed a methodology for reproducible biomarker discovery for 16s rRNA microbiome sequence analysis, addressing the issues related with data dimensionality, inconsistent results and validation across independent datasets. The findings from the three experiments, across 9 different datasets, show that the proposed methodology achieved higher accuracy compared to other feature selection methods. This methodology is a first approach to increase reproducibility, to provide robust and reliable results.

Keywords: Machine learning; Microbiome; Reproducibility.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no competing interests.

Figures

Fig. 1
Fig. 1
a The minimum number of features to obtain the higher accuracy, b Plot of the classifier with the best performance in the validation process for discovery dataset David et al, c Plot of the classifier with the best performance in the validation process for PRJNA589343, and d Plot of the classifier with the best performance in the validation process for PRJNA578223
Fig. 2
Fig. 2
a The minimum number of features to obtain the higher accuracy, b Plot of the classifier with the best performance in the validation process for discovery dataset PRJEB2150, c Plot of the classifier with the best performance in the validation process for DRA00609, and d Plot of the classifier with the best performance in the validation process for PRJNA684584
Fig. 3
Fig. 3
a The minimum number of features to obtain the higher accuracy, b Plot of the classifier with the best performance in the validation process for discovery dataset PRJNA325931, c Plot of the classifier with the best performance in the validation process for PRJNA554535, and d Plot of the classifier with the best performance in the validation process for PRJEB53017
Fig. 4
Fig. 4
Overview of the proposed methodology. The upper shows the workflow for the dataset selection criteria, raw data processing and feature selection phases. The lower part shows the testing phase workflow
Fig. 5
Fig. 5
Overview of the datasets used for each experiment

References

    1. Cani PD. Human gut microbiome: hopes, threats and promises. Gut. 2018;67(9):1716–1725. doi: 10.1136/gutjnl-2018-316723. - DOI - PMC - PubMed
    1. Khan I, Ullah N, Zha L, Bai Y, Khan A, Zhao T, Che T, Zhang C. Alteration of gut microbiota in inflammatory bowel disease (ibd): Cause or consequence? ibd treatment targeting the gut microbiome. Pathogens. 2019;8(3):126. doi: 10.3390/pathogens8030126. - DOI - PMC - PubMed
    1. Dickson I. Diagnosing ibd with the gut microbiome. Nat Rev Gastroenterol Hepatol. 2017;14(4):195–195. doi: 10.1038/nrgastro.2017.25. - DOI - PubMed
    1. McIlroy J, Ianiro G, Mukhopadhya I, Hansen R, Hold G. the gut microbiome in inflammatory bowel disease-avenues for microbial management. Aliment Pharmacol Ther. 2018;47(1):26–42. doi: 10.1111/apt.14384. - DOI - PubMed
    1. Michail S, Durbin M, Turner D, Griffiths AM, Mack DR, Hyams J, Leleiko N, Kenche H, Stolfi A, Wine E. Alterations in the gut microbiome of children with severe ulcerative colitis. Inflamm Bowel Dis. 2012;18(10):1799–1808. doi: 10.1002/ibd.22860. - DOI - PMC - PubMed